UWMC vs. IOVA

Last updated Apr 2, 2026

Compare and contrast key facts about UWM Holdings Corporation (UWMC) and Iovance Biotherapeutics, Inc. (IOVA).

Performance

UWMC vs. IOVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UWM Holdings Corporation (UWMC) and Iovance Biotherapeutics, Inc. (IOVA). The values are adjusted to include any dividend payments, if applicable.

UWMC vs. IOVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
UWMC UWM Holdings Corporation	-14.58%	-19.30%	-13.04%	132.11%	-38.03%	-28.60%
IOVA Iovance Biotherapeutics, Inc.	26.37%	-63.11%	-8.98%	27.23%	-66.53%	-39.91%

Fundamentals

Market Cap UWMC : $9.35B IOVA : $1.40B
EPS UWMC : $0.10 IOVA : -$1.06
PS Ratio UWMC : 1.91 IOVA : 4.82
PB Ratio UWMC : 5.87 IOVA : 2.01
Total Revenue (TTM) UWMC : $3.16B IOVA : $263.50M
Gross Profit (TTM) UWMC : $1.01B IOVA : $256.22M
EBITDA (TTM) UWMC : $135.33M IOVA : -$357.11M

Returns By Period

In the year-to-date period, UWMC achieves a -14.58% return, which is significantly lower than IOVA's 26.37% return.

UWMC

• 1D: 0.55%
• 1M: -13.59%
• YTD: -14.58%
• 6M: -38.98%
• 1Y: -25.63%
• 3Y*: -2.81%
• 5Y*: -7.29%
• 10Y*: —

IOVA

• 1D: -1.71%
• 1M: -8.97%
• YTD: 26.37%
• 6M: 56.11%
• 1Y: 6.15%
• 3Y*: -17.35%
• 5Y*: -36.04%
• 10Y*: -4.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UWMC vs. IOVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UWMC

UWMC Risk / Return Rank: 21
UWMC Sharpe Ratio Rank: 21
UWMC Sortino Ratio Rank: 22
UWMC Omega Ratio Rank: 22
UWMC Calmar Ratio Rank: 21
UWMC Martin Ratio Rank: 20

IOVA

IOVA Risk / Return Rank: 46
IOVA Sharpe Ratio Rank: 42
IOVA Sortino Ratio Rank: 53
IOVA Omega Ratio Rank: 53
IOVA Calmar Ratio Rank: 42
IOVA Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UWMC vs. IOVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UWM Holdings Corporation (UWMC) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UWMC	IOVA	Difference
Sharpe ratio Return per unit of total volatility	-0.45	0.06	-0.50
Sortino ratio Return per unit of downside risk	-0.32	0.96	-1.29
Omega ratio Gain probability vs. loss probability	0.96	1.13	-0.17
Calmar ratio Return relative to maximum drawdown	-0.57	0.07	-0.64
Martin ratio Return relative to average drawdown	-1.10	0.10	-1.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UWMC vs. IOVA - Sharpe Ratio Comparison

The current UWMC Sharpe Ratio is -0.45, which is lower than the IOVA Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of UWMC and IOVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UWMC	IOVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.45	0.06	-0.50
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.14	-0.40	+0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.18	-0.14	-0.04

Correlation

The correlation between UWMC and IOVA is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UWMC vs. IOVA - Dividend Comparison

UWMC's dividend yield for the trailing twelve months is around 10.99%, while IOVA has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021
UWMC UWM Holdings Corporation	10.99%	9.13%	6.81%	5.59%	12.08%	6.76%
IOVA Iovance Biotherapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

UWMC vs. IOVA - Drawdown Comparison

The maximum UWMC drawdown since its inception was -68.67%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for UWMC and IOVA.

Drawdown Indicators

	UWMC	IOVA	Difference
Max Drawdown Largest peak-to-trough decline	-68.67%	-99.37%	+30.70%
Max Drawdown (1Y) Largest decline over 1 year	-47.27%	-54.41%	+7.14%
Max Drawdown (5Y) Largest decline over 5 years	-68.67%	-94.98%	+26.31%
Max Drawdown (10Y) Largest decline over 10 years	—	-96.84%	—
Current Drawdown Current decline from peak	-56.25%	-97.83%	+41.58%
Average Drawdown Average peak-to-trough decline	-36.44%	-84.01%	+47.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.64%	37.79%	-13.15%

Volatility

UWMC vs. IOVA - Volatility Comparison

The current volatility for UWM Holdings Corporation (UWMC) is 13.42%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 30.95%. This indicates that UWMC experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UWMC	IOVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.42%	30.95%	-17.53%
Volatility (6M) Calculated over the trailing 6-month period	40.65%	65.58%	-24.93%
Volatility (1Y) Calculated over the trailing 1-year period	57.32%	112.15%	-54.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.76%	90.77%	-40.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	50.77%	81.91%	-31.14%

Financials